Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

80.92 -0.64 (-0.79%)
Streaming Delayed Price Updated: 11:38 AM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Why Jim Cramer Likes Illumina, SoFi And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said SoFi Technologies, Inc’s (NASDAQ: 
Via Benzinga
GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test
From GRAIL, LLC
Via Business Wire
Illumina Ranked #2 on Newsweek's America's Most Responsible Companies 2022 List
SOURCE: Illumina 
Via 3BL Media
Illumina and Sequoia Capital China Select First Startups to Join Genomics Incubator in China
SOURCE: Illumina 
Via 3BL Media
Illumina Selected As a Best Place to Work in Biopharma
SOURCE: Illumina 
Via 3BL Media
Illumina Salutes Service Members on Veterans Day
SOURCE: Illumina 
Via 3BL Media
Illumina Named Best for Vets Employer
SOURCE: Illumina 
Via 3BL Media
Topics Supply Chain
Exposures Supply Chain
Bionano Genomics Proves Not Everything Genetic is Gold
Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes. 
Via InvestorPlace
10x Genomics Stock: Bull vs. Bear
After a hot start, the stock has recently lagged the market. Is now a good time to buy? 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Wait for Bionano Stock to Fall Further Before Buying
BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term. 
Via InvestorPlace
Proteomics Market Worth $55.9 Billion by 2026 - Size, Share, Developments, Opportunities, Key Players Analysis
Northbrook, IL -- (SBWIRE) -- 11/22/2021 -- Proteomics Market Research Report Provides Crucial Industry Insights. Industry to Witness a Steady Growth in Near Future. 
Via SBWire
Illumina's Shanghai Employees and Families Help Conserve Wetland Reserve
SOURCE: Illumina 
Via 3BL Media
Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Major Statistics & Growth Dynamics
Northbrook, IL -- (SBWIRE) -- 11/19/2021 -- Single-cell Analysis Market Research Report Provides Crucial Industry Insights. Industry to Witness a Steady Growth in Near Future. 
Via SBWire
Following Rough Year, Is Burning Rock Set To Turn The Corner?
Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China Cancer testing specialist’s... 
Via Benzinga
Europe To Layout Objections to Illumina-Grail Deal: Bloomberg
Illumina Inc (NASDAQ: ILMN) says the European Union will issue a list of objections tomorrow over the Company's $8B takeover of GRAIL, Bloomberg reports. Related... 
Via Benzinga
Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease
SOURCE: Illumina 
Via 3BL Media
Topics Religion
Exposures Religion
Illumina Named to 2021 Dow Jones Sustainability Indices With Highest Score in Pharmaceuticals, Biotechnology and Life Sciences Industry
SOURCE: Illumina 
Via 3BL Media
Topics Stocks
Exposures US Equities
Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force... 
Via FinancialNewsMedia
Bioinformatics Market Worth $21.8 Billion by 2026 - Size, Industry Trends, Key Players and Forecast
Northbrook, IL -- (SBWIRE) -- 11/10/2021 -- Bioinformatics Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow. 
Via SBWire
Exposures COVID-19
Illumina Clocks 40% Growth In Q3; Earnings Beat Expectations
Illumina Inc (NASDAQ: ILMN) reported Q3 revenues of $1.11 billion, +40% Y/Y, beating the consensus of $1.04 billion. Consolidated Product revenues were $978 million,... 
Via Benzinga
Topics Earnings
Exposures Financial
Illumina, inc (ILMN) Q3 2021 Earnings Call Transcript
ILMN earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
After Its Grail Buyout, Illumina Beats Third-Quarter Expectations
Illumina stock inched higher late Thursday after the company beat forecasts. 
Via Investor's Business Daily
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
Illumina Named a World's Top-Female Friendly Company by Forbes
SOURCE: Illumina 
Via 3BL Media
NASDAQ: ILMN Investor Notice: Investigation over Potential Wrongdoing at Illumina, Inc.
San Diego, CA -- (SBWIRE) -- 10/29/2021 -- An investigation on behalf of investors in Illumina, Inc. (NASDAQ: ILMN) shares over potential wrongdoing at Illumina, Inc. was announced. 
Via SBWire
Sequencing to Save the Lemurs: A Collaboration Between the San Diego Zoo Wildlife Alliance and Illumina
SOURCE: Illumina 
Via 3BL Media
Microfluidics Market Worth $58.8 Billion by 2026 - Size, Share, Growth and Trend Analysis Report
Northbrook, IL -- (SBWIRE) -- 10/28/2021 -- According to the new market research report "Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC,... 
Via SBWire
Exposures COVID-19
Illumina Supports Israel's National Program to Accelerate Diagnoses of Critically-Ill Newborns with Suspected Genetic Disease
SOURCE: Illumina 
Via 3BL Media
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.